Advertisement

Topics

Roche sells rights to troubled asthma and eczema drug

06:40 EDT 9 Aug 2017 | pharmaphorum

Once considered a highlight of Roche’s late stage pipeline, the Swiss company said a year ago it was “assessing options” for lebrikizumab after mixed results in two late-stage asthma trials. Now dermatology specialist Dermira has lifted the ...

Original Article: Roche sells rights to troubled asthma and eczema drug

NEXT ARTICLE

More From BioPortfolio on "Roche sells rights to troubled asthma and eczema drug"

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Allergies
The term allergy is used to describe a response, within the body, to a substance, which is not necessarily harmful in itself, but results in an immune response and a reaction that causes symptoms and disease in a predisposed person, which in turn can cau...

Dermatology
Acne Dermatology Eczema Psoriasis Wound Care Dermatology is the medical specialty concerned with the diagnosis and treatment of skin disorders (Oxford Medical Dictionary). As well as studying how the skin works, dermatology covers...